Integer Holdings (ITGR) Income from Non-Controlling Interests (2010 - 2018)
Integer Holdings (ITGR) reported Income from Non-Controlling Interests of $3.4 million for Q1 2018, up 94.8% on a YoY basis from $1.8 million in Q1 2017, and up 563.23% sequentially from $514000.0 in Q4 2017.
Integer Holdings (ITGR) Income from Non-Controlling Interests (2010 - 2018) Analysis & Trends
Integer Holdings (ITGR) has 9 years of Income from Non-Controlling Interests data on file, last reported at $3.4 million in Q1 2018.
- For the quarter ending Q1 2018, Income from Non-Controlling Interests rose 94.8% year-over-year to $3.4 million; the trailing twelve-month figure through Mar 2018 stood at $3.9 million (up 1.06% YoY), and the FY2018 full-year result was $16000.0, down 99.29% from the prior year.
- Income from Non-Controlling Interests improved to $3.4 million in Q1 2018, from $514000.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $3.4 million in Q1 2018 to a low of -$1.2 million in Q3 2016.
- A 5-year average of $483588.2 and a median of $86000.0 in 2014 frame the typical range for Income from Non-Controlling Interests.
- Peak annual rise in Income from Non-Controlling Interests reached 46550.0% in 2016, while the deepest fall reached 1301.12% in 2016.
- Tracing ITGR's Income from Non-Controlling Interests over 5 years: stood at -$49000.0 in 2014, then jumped by 1506.12% to $689000.0 in 2015, then surged by 304.5% to $2.8 million in 2016, then plunged by 81.56% to $514000.0 in 2017, then surged by 563.23% to $3.4 million in 2018.
- Business Quant data shows ITGR's Income from Non-Controlling Interests at $3.4 million in Q1 2018, $514000.0 in Q4 2017, and -$339000.0 in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -5.85 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Integer Holdings | 3.34 Bn | 3.33 Bn | 109.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2018 | 3.41 Mn |
| Dec 29, 2017 | 514,000.00 |
| Sep 29, 2017 | -339,000.00 |
| Jun 30, 2017 | 318,000.00 |
| Mar 31, 2017 | 1.75 Mn |
| Dec 30, 2016 | 2.79 Mn |
| Sep 30, 2016 | 571,000.00 |
| Jul 1, 2016 | -1.25 Mn |
| Apr 1, 2016 | 367,000.00 |
| Jan 1, 2016 | -6,000.00 |
| Oct 2, 2015 | 689,000.00 |
| Jul 3, 2015 | -89,000.00 |
| Apr 3, 2015 | -600,000.00 |
| Oct 3, 2014 | -49,000.00 |
| Jul 4, 2014 | 86,000.00 |
| Apr 4, 2014 | 77,000.00 |
| Jan 3, 2014 | -17,000.00 |
| Sep 27, 2013 | -403,000.00 |
| Jun 28, 2013 | -231,000.00 |
| Mar 29, 2013 | 269,000.00 |